课题基金 / 基金详情

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases
用于以患者为导向的传染病现场研究的分子诊断工具
批准号:
10443710
负责人:
ERIC R HOUPT
金额:
$15.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2024-06-30

项目摘要

项目成果

ERIC R HOUPT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I am a Clinician Investigator in the Division of Infectious Diseases at University of Virginia and am submitting this one-time K24 renewal application to further extend my molecular diagnostics research into patient oriented research (POR) and to provide protected time to mentor both my direct and institutional trainees. In the 15 years since completion of ID fellowship I have developed a research program in several domains of tropical infectious diseases, now largely focused on the development of molecular diagnostic tools for research. Aim 1: In the first term of this grant I established the University of Virginia School of Medicine K-award mentoring program, which entails a series of Symposia and meetings geared towards both those applying for and those who have already received NIH K or similar awards. This K24 grant will allow me to continue and extend this important program further. This grant will also allow protected time to directly mentor my trainees in POR, which currently consists of 3 K23 recipients and 1 Infectious Disease fellow, working in areas spanning MDR TB, pediatric TB, childhood diarrhea, and antimicrobial resistance, each with a diagnostic emphasis. Aim 2: I will also extend my personal research program into POR. Currently funded work includes the use of molecular diagnostics for both case- and population-level etiologic diagnosis of diarrhea and molecular diagnosis of MDR Tuberculosis. The most mature work involves diarrheal etiology, and our latest data strongly supports entering into clinical trials for Enterotoxigenic E. coli vaccines and new Cryptosporidium therapeutics. This K24 will allow me protected time to insert these molecular diagnostics into these trials as primary or secondary outcomes and gain needed skills in clinical trial design and data analysis. Finally, consonant with the K24 mechanism, I will expand my research new areas such as molecular diagnostics for antimicrobial resistance.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0264322
发表时间: 2022
期刊: PloS one
影响因子: 3.7
作者: [Mduma E, Halidou T, Kaboré B, Walongo T, Lompo P, Museveni J, Gidabayda J, Gratz J, Guga G, Kimathi C, Liu J, Mdoe P, Moshiro R, Petzold M, Singlovic J, Guillerm M, Gomes MF, Houpt ER, Halleux CM]
通讯作者: Halleux CM
Evaluation of Molecular Serotyping Assays for Shigella flexneri Directly on Stool Samples.
直接在粪便样品上的志贺氏菌柔韧性分子血清分型测定评估。
DOI: 10.1128/jcm.02455-20
发表时间: 2021-01-21
期刊: Journal of clinical microbiology
影响因子: 9.4
作者: [Liu J, Pholwat S, Zhang J, Taniuchi M, Haque R, Alam M, Ochieng JB, Jones JA, Platts-Mills JA, Tennant SM, Houpt E]
通讯作者: Houpt E
DOI: 10.1093/cid/ciaa421
发表时间: 2021-07-15
期刊: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子: --
作者: [Iroh Tam P, Arnold SLM, Barrett LK, Chen CR, Conrad TM, Douglas E, Gordon MA, Hebert D, Henrion M, Hermann D, Hollingsworth B, Houpt E, Jere KC, Lindblad R, Love MS, Makhaza L, McNamara CW, Nedi W, Nyirenda J, Operario DJ, Phulusa J, Quinnan GV, Sawyer LA, Thole H, Toto N, Winter A, Van Voorhis WC]
通讯作者: Van Voorhis WC
DOI: 10.4269/ajtmh.21-0814
发表时间: 2021-11-08
期刊: The American journal of tropical medicine and hygiene
影响因子: --
作者: [Grundy B, Panzner U, Liu J, Jeon HJ, Im J, von Kalckreuth V, Konings F, Pak GD, Cruz Espinoza LM, Bassiahi AS, Gasmelseed N, Rakotozandrindrainy R, Stroup S, Houpt ER, Marks F]
通讯作者: Marks F
9
    Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
    • 批准号:
      10543980
    • 项目类别:
    • 资助金额:
      $67.36万
    • 财政年份:
      2021
    • 负责人:
      ERIC R HOUPT
    • 依托单位:
    Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
    • 批准号:
      10321219
    • 项目类别:
    • 资助金额:
      $67.54万
    • 财政年份:
      2021
    • 负责人:
      ERIC R HOUPT
    • 依托单位:
    Diagnostics and Pharmacotherapy for Severe Forms of TB
    • 批准号:
      9127086
    • 项目类别:
    • 资助金额:
      $67.39万
    • 财政年份:
      2015
    • 负责人:
      ERIC R HOUPT
    • 依托单位:
    Diagnostics and Pharmacotherapy for Severe Forms of TB
    • 批准号:
      8819855
    • 项目类别:
    • 资助金额:
      $38.47万
    • 财政年份:
      2015
    • 负责人:
      ERIC R HOUPT
    • 依托单位:
    国内基金
    海外基金
    层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
    • 批准号:
      2021JJ40433
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      孙磊
    • 依托单位:
    寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
    • 批准号:
      32001603
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      段真珍
    • 依托单位:
    AREA国际经济模型的移植.改进和应用
    • 批准号:
      18870435
    • 项目类别:
      面上项目
    • 资助金额:
      2.0万元
    • 批准年份:
      1988
    • 负责人:
      史树中
    • 依托单位: